{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:40:15Z","timestamp":1790174415428,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.09.009","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T08:54:35Z","timestamp":1574412875000},"page":"6-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinaemia: clinicopathological features and differential diagnosis"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-4556","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.009_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"232","article-title":"Lymphoplasmacytic lymphoma","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.009_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0954-6820.1944.tb03955.x","article-title":"Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia: a new syndrome?","volume":"117","author":"Waldenstrom","year":"1944","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.pathol.2019.09.009_bib3","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/sj.leu.2403991","article-title":"Familial aggregation of lymphoplasmacytic lymphoma with non-hodgkin lymphoma and other neoplasms","volume":"19","author":"Altieri","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.009_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.12760","article-title":"Guidelines on the diagnosis and management of Waldenstrom macroglobulinaemia","volume":"165","author":"Owen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.009_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/annonc\/mdj111","article-title":"Characterization of familial Waldenstrom's macroglobulinemia","volume":"17","author":"Treon","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.09.009_bib6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A\u00a0role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.009_bib7","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1182\/blood.V84.9.3047.3047","article-title":"Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia","volume":"84","author":"Pozzato","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/PAP.0b013e31824019d0","article-title":"Waldenstrom macroglobulinemia: a review of the entity and its differential diagnosis","volume":"19","author":"Shaheen","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jncimonographs\/lgu002","article-title":"Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma\/Waldenstrom's macroglobulinemia: the interlymph non-Hodgkin lymphoma subtypes project","volume":"2014","author":"Vajdic","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.pathol.2019.09.009_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3816\/CLML.2011.n.011","article-title":"IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenstrom's macroglobulinemia (SWM)","volume":"11","author":"Kyle","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.pathol.2019.09.009_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3816\/CLM.2005.n.011","article-title":"Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance","volume":"5","author":"Kyle","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.009_bib12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.009_bib13","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V97.1.321","article-title":"Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor","volume":"97","author":"Ciric","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(85)90123-8","article-title":"Evidence for the biclonal nature of a Waldenstrom's macroglobulinemia","volume":"146","author":"Bonewald","year":"1985","journal-title":"Clin Chim Acta Med Scand"},{"key":"10.1016\/j.pathol.2019.09.009_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1084-8592(96)70001-2","article-title":"Molecular analysis in a patient with Waldenstrom's macroglobulinemia reveals a rare case of biclonality","volume":"1","author":"Schulz","year":"1996","journal-title":"Mol Diagn"},{"key":"10.1016\/j.pathol.2019.09.009_bib17","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1158\/1078-0432.CCR-06-2788","article-title":"Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences","volume":"13","author":"Kriangkum","year":"2007","journal-title":"Clin J Natl Cancer Inst Monogr Res"},{"key":"10.1016\/j.pathol.2019.09.009_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pathol.2018.10.022","article-title":"Biclonal presentation of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinaemia","volume":"51","author":"Wang","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2019.09.009_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajh.24557","article-title":"Waldenstrom macroglobulinemia: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gertz","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.09.009_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.23880","article-title":"Extramedullary waldenstrom macroglobulinemia","volume":"90","author":"Banwait","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2019.09.009_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.14743","article-title":"Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstrom macroglobulinaemia","volume":"177","author":"Gustine","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.009_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1309\/2A0FL1HM5PN2510P","article-title":"Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients","volume":"123","author":"Lin","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3816\/CLM.2005.n.006","article-title":"Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders","volume":"5","author":"Pangalis","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.pathol.2019.09.009_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.1993.11.5.914","article-title":"Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenstrom's macroglobulinemia","volume":"11","author":"Gertz","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.009_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood-2015-01-553974","article-title":"How i treat Waldenstrom macroglobulinemia","volume":"126","author":"Treon","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1309\/AJCP6ZODWV1CIDME","article-title":"Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature","volume":"143","author":"Bassarova","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1309\/AJCP8FOIVTB6LBER","article-title":"Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation","volume":"136","author":"Lin","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3816\/CLM.2009.n.013","article-title":"Assessment of bone marrow response in Waldenstrom's macroglobulinemia","volume":"9","author":"Varghese","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.pathol.2019.09.009_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1309\/AJCP15YFULCZHZVH","article-title":"Residual monotypic plasma cells in patients with Waldenstrom macroglobulinemia after therapy","volume":"135","author":"Barakat","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00000478-200308000-00007","article-title":"Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients","volume":"27","author":"Lin","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1309\/6U88-357U-UKJ5-YPT3","article-title":"Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course","volume":"116","author":"Mansoor","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/R01VXG46MFCDVNHL","article-title":"Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases","volume":"120","author":"Lin","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/his.12768","article-title":"Crystal-storing histiocytosis: a clinicopathological study of 13 cases","volume":"68","author":"Kanagal-Shamanna","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.009_bib34","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2014.120","article-title":"MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma","volume":"28","author":"Hamadeh","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.hoc.2018.05.004","article-title":"Flow cytometry","volume":"32","author":"Gascue","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.pathol.2019.09.009_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1309\/3G1XDX0DVHBNVKB4","article-title":"Immunophenotypic profile of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia","volume":"124","author":"Konoplev","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/modpathol.2015.122","article-title":"TCL1 expression patterns in Waldenstrom macroglobulinemia","volume":"29","author":"Lemal","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib38","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2009.34","article-title":"Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia","volume":"22","author":"Morice","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bjh.13303","article-title":"Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process","volume":"169","author":"Rosado","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.009_bib40","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood.V83.12.3647.3647","article-title":"Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma","volume":"83","author":"Wagner","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib41","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V100.4.1505.h81602001505_1505_1507","article-title":"Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events","volume":"100","author":"Sahota","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1073\/pnas.94.1.208","article-title":"Memory B lymphocytes migrate to bone marrow in humans","volume":"94","author":"Paramithiotis","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.009_bib43","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood.V100.8.2996","article-title":"Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions","volume":"100","author":"Schop","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3816\/CLM.2009.n.008","article-title":"Prognostic relevance of 6q deletion in Waldenstrom's macroglobulinemia: a multicenter study","volume":"9","author":"Chang","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.pathol.2019.09.009_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3324\/haematol.2012.070458","article-title":"Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom's macroglobulinemia","volume":"98","author":"Nguyen-Khac","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.009_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.009_bib47","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia","volume":"27","author":"Jimenez","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.009_bib48","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2012-06-436329","article-title":"MYD88 L265P mutation in Waldenstrom macroglobulinemia","volume":"121","author":"Poulain","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib49","first-page":"2457","article-title":"MYD88 L265P mutation in lymphoid malignancies","volume":"78","author":"Yu","year":"2018","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.pathol.2019.09.009_bib50","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcp\/aqw072","article-title":"Lymphoplasmacytic lymphoma with a non-IgM paraprotein shows clinical and pathologic heterogeneity and may harbor MYD88 L265P mutations","volume":"145","author":"King","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib51","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","article-title":"Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome","volume":"123","author":"Martinez-Trillos","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib52","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood-2015-05-648634","article-title":"Prognostic relevance of MYD88 mutations in CLL: the jury is still out","volume":"126","author":"Baliakas","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib53","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2015-10-678490","article-title":"Clinical impact of MYD88 mutations in chronic lymphocytic leukemia","volume":"127","author":"Martinez-Trillos","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib54","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2019.09.009_bib56","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis","volume":"123","author":"Hunter","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib57","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2014-01-550905","article-title":"Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia","volume":"123","author":"Treon","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib58","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1501548","article-title":"Ibrutinib in previously treated Waldenstrom's macroglobulinemia","volume":"372","author":"Treon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.009_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","article-title":"How I manage monoclonal gammopathy of undetermined significance","volume":"131","author":"Go","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib60","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"236","article-title":"IgM monoclonal gammopathy of undetermined significance","author":"Cook","year":"2017"},{"key":"10.1016\/j.pathol.2019.09.009_bib61","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1309\/HRHQFBFTR8B4LXT4","article-title":"Bone marrow involvement by marginal zone B-cell lymphomas of different types","volume":"129","author":"Inamdar","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib62","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bjh.15584","article-title":"CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation","volume":"184","author":"Raimbault","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.009_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.humpath.2018.09.008","article-title":"IgM plasma cell myeloma in the era of novel therapy: a clinicopathological study of 17 cases","volume":"84","author":"Angelova","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.009_bib64","first-page":"10","article-title":"Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma, a diagnostic challenge","volume":"7","author":"Mansour","year":"2017","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.pathol.2019.09.009_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3960\/jslrt.53.29","article-title":"Simultaneous presentation of Waldenstrom macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up","volume":"53","author":"Carulli","year":"2013","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.pathol.2019.09.009_bib66","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2014.108688","article-title":"Gamma heavy chain disease lacks the MYD88 L265P mutation associated with lymphoplasmacytic lymphoma","volume":"99","author":"Hamadeh","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.009_bib67","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstrom macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.009_bib68","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.16088","article-title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstrom macroglobulinaemia treated with Ibrutinib","volume":"187","author":"Castillo","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.009_bib69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjh.15560","article-title":"TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenstrom macroglobulinaemia","volume":"184","author":"Gustine","year":"2019","journal-title":"Br J Haematol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T13:44:46Z","timestamp":1577454286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519304192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519304192"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.009","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinaemia: clinicopathological features and differential diagnosis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}